These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vectors for gene therapy of cardiovascular disease. Dedieu JF; Mahfoudi A; Le Roux A; Branellec D Curr Cardiol Rep; 2000 Jan; 2(1):39-47. PubMed ID: 10980871 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Kingston PA; Sinha S; David A; Castro MG; Lowenstein PR; Heagerty AM Circulation; 2001 Nov; 104(21):2595-601. PubMed ID: 11714656 [TBL] [Abstract][Full Text] [Related]
6. Recent Advancements in Cardiovascular Gene Therapy and Vascular Biology. Laakkonen JP; Ylä-Herttuala S Hum Gene Ther; 2015 Aug; 26(8):518-24. PubMed ID: 26192706 [TBL] [Abstract][Full Text] [Related]
9. Adenoviral vector-mediated gene transfer for human gene therapy. Breyer B; Jiang W; Cheng H; Zhou L; Paul R; Feng T; He TC Curr Gene Ther; 2001 Jul; 1(2):149-62. PubMed ID: 12108952 [TBL] [Abstract][Full Text] [Related]
10. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Fishbein I; Alferiev I; Bakay M; Stachelek SJ; Sobolewski P; Lai M; Choi H; Chen IW; Levy RJ Circulation; 2008 Apr; 117(16):2096-103. PubMed ID: 18413497 [TBL] [Abstract][Full Text] [Related]
11. The emerging role of gene therapy in the treatment of cardiovascular diseases. Barbato JE; Kibbe MR; Tzeng E Crit Rev Clin Lab Sci; 2003 Oct; 40(5):499-545. PubMed ID: 14653356 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy for cardiovascular diseases. Gruchala M; Roy H; Bhardwaj S; Ylä-Herttuala S Curr Pharm Des; 2004; 10(4):407-23. PubMed ID: 14965202 [TBL] [Abstract][Full Text] [Related]
13. Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? Dzau VJ Am J Cardiol; 2003 Nov; 92(9B):32N-35N. PubMed ID: 14615024 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus vectors composed of subgroup B adenoviruses. Sakurai F; Kawabata K; Mizuguchi H Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556 [TBL] [Abstract][Full Text] [Related]
15. Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature. Nicol CG; Denby L; Lopez-Franco O; Masson R; Halliday CA; Nicklin SA; Kritz A; Work LM; Baker AH FEBS Lett; 2009 Jun; 583(12):2100-7. PubMed ID: 19481546 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology. Mitra AK; Agrawal DK Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206 [TBL] [Abstract][Full Text] [Related]
17. Novel vectors for in vivo gene delivery to vascular tissue. White K; Nicklin SA; Baker AH Expert Opin Biol Ther; 2007 Jun; 7(6):809-21. PubMed ID: 17555367 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for atherosclerotic cardiovascular disease: a time for optimism and caution. O'Brien T; Simari RD Mayo Clin Proc; 2000 Aug; 75(8):831-4. PubMed ID: 10943238 [TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system. Zacchigna S; Zentilin L; Giacca M Circ Res; 2014 May; 114(11):1827-46. PubMed ID: 24855205 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy in cardiovascular diseases: A review of recent updates. Gorabi AM; Hajighasemi S; Tafti HA; Soleimani M; Panahi Y; Ganjali S; Sahebkar A J Cell Biochem; 2018 Dec; 119(12):9645-9654. PubMed ID: 30129172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]